Inhibition of type I PRMTs reforms muscle stem cell identity enhancing their therapeutic capacity.

Saved in:
Bibliographic Details
Title: Inhibition of type I PRMTs reforms muscle stem cell identity enhancing their therapeutic capacity.
Authors: Dominici C; Segal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada.; Departments of Human Genetics, McGill University, Montreal, Canada., Villarreal OD; Segal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada., Dort J; CHU Sainte-Justine Research Center, Université de Montréal, Montréal, Canada., Heckel E; CHU Sainte-Justine Research Center, Université de Montréal, Montréal, Canada., Wang YC; Genome Quebec Innovation Centre, Montreal, Canada., Ragoussis I; Genome Quebec Innovation Centre, Montreal, Canada., Joyal JS; CHU Sainte-Justine Research Center, Université de Montréal, Montréal, Canada., Dumont N; CHU Sainte-Justine Research Center, Université de Montréal, Montréal, Canada., Richard S; Segal Cancer Center, Lady Davis Institute for Medical Research, McGill University, Montreal, Canada.; Departments of Human Genetics, McGill University, Montreal, Canada.; Gerald Bronfman, Department of Oncology, McGill University, Montréal, Canada.; Departments of Medicine, McGill University, Montreal, Canada.; Departments of Biochemistry, McGill University, Montréal, Canada.
Source: ELife [Elife] 2023 Jun 07; Vol. 12. Date of Electronic Publication: 2023 Jun 07.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2050-084X
DOI:10.7554/eLife.84570